Weight Loss Medication Protocol: Standard Treatment Approaches
hi-doctor.ai BlogFebruary 1, 2026

Weight Loss Medication Protocol: Standard Treatment Approaches

Table of contents

Understanding Weight Loss Medication Protocols

Weight loss medication protocols offer a structured approach to managing obesity and achieving sustainable weight loss. These protocols typically involve a combination of lifestyle modifications, such as diet and exercise, along with prescription medications. The goal is to create a comprehensive plan that addresses the underlying causes of weight gain and promotes long-term health.

Key Point 1 Weight loss medication protocols combine lifestyle changes with prescription drugs for effective weight management.

Key Point 2 GLP-1 receptor agonists like Semaglutide and Tirzepatide are highly effective for significant weight loss.

Key Point 3 Orlistat, a non-GLP-1 option, works by blocking fat absorption in the gut.

Key Point 4 Medical supervision is crucial for safe and effective weight loss medication use.

Common Weight Loss Medications

Several medications are commonly used in weight loss protocols. These include GLP-1 receptor agonists and Orlistat. Each medication works differently and has its own set of benefits and considerations.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

GLP-1 Receptor Agonists

GLP-1 receptor agonists are a class of medications that mimic the effects of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). These medications work by:

  • Regulating Appetite: GLP-1 agonists reduce appetite and food cravings by acting on the brain's appetite centers.
  • Slowing Gastric Emptying: They slow down the rate at which food empties from the stomach, leading to increased feelings of fullness.
  • Improving Blood Sugar Control: GLP-1 agonists stimulate insulin release from the pancreas, which helps lower blood sugar levels.

Examples of GLP-1 receptor agonists include:

  • Semaglutide (Wegovy): Semaglutide is administered as a weekly injection and has shown significant weight loss results. Clinical trials have demonstrated an average weight loss of 15-17% after 68 weeks.
  • Tirzepatide (Mounjaro): Tirzepatide is a dual-action medication that acts as both a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. It is also administered as a weekly injection and has shown even more impressive weight loss results, with an average weight loss of 22.5% after 72 weeks.
  • Liraglutide (Saxenda): Liraglutide is another GLP-1 receptor agonist administered as a daily injection. It has been shown to produce an average weight loss of around 8% after 56 weeks.

Orlistat

Orlistat is a different type of weight loss medication that works by blocking the absorption of fat in the gut. It inhibits the enzyme lipase, which is responsible for breaking down dietary fats. As a result, about 30% of the fat consumed is not absorbed and is instead excreted in the stool.

  • Mechanism: Orlistat reduces the amount of fat absorbed from the diet.
  • Administration: It is taken orally with meals.
  • Results: Studies show an average weight loss of 5-10% after 52 weeks.

Treatment Protocols and Timelines

A typical weight loss medication protocol involves several phases, each with specific goals and strategies. The timeline can vary depending on the individual and the medication used.

Initial Assessment

Before starting any weight loss medication, a thorough medical evaluation is necessary. This includes:

  • Medical History: Review of past and current health conditions.
  • Physical Exam: Assessment of vital signs and overall health.
  • Lifestyle Evaluation: Discussion of diet, exercise habits, and other lifestyle factors.

Initiation Phase

This phase involves starting the medication at a low dose and gradually increasing it to the target dose. For GLP-1 receptor agonists, this titration process helps minimize side effects.

  • Semaglutide (Wegovy): The starting dose is typically 0.25 mg per week, which is gradually increased every 4 weeks until reaching the maintenance dose of 2.4 mg per week.
  • Tirzepatide (Mounjaro): The starting dose is 2.5 mg per week, which is gradually increased every 4 weeks to a maximum of 15 mg per week.
  • Liraglutide (Saxenda): The starting dose is 0.6 mg per day, which is increased weekly to a maximum of 3.0 mg per day.

Maintenance Phase

Once the target dose is reached, the focus shifts to maintaining weight loss through continued medication use and lifestyle modifications.

  • Regular Monitoring: Regular check-ups with a healthcare provider to monitor progress and address any concerns.
  • Lifestyle Support: Continued support for diet and exercise to reinforce healthy habits.

Timeline

  • Week 1-4 (Month 1): Adjustment to medication, initial appetite reduction, and early weight loss.
  • Month 2-3: Consistent weight loss, visible changes in body composition, and improved energy levels.
  • Month 4-6: Significant weight loss (10-15% or more), reaching target weight, and establishing maintenance habits.
  • Month 6+: Long-term maintenance of healthy weight, with continued medical support.

Potential Side Effects and Considerations

Like all medications, weight loss drugs can cause side effects. It’s important to be aware of these potential issues and discuss them with your healthcare provider.

Common Side Effects

  • GLP-1 Receptor Agonists: Nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects are usually mild and temporary.
  • Orlistat: Oily stools, flatulence, and fecal urgency. These side effects are related to the increased excretion of fat in the stool.

Serious Considerations

  • Pancreatitis: GLP-1 receptor agonists have been linked to an increased risk of pancreatitis.
  • Gallbladder Problems: Rapid weight loss can increase the risk of gallstones.
  • Kidney Problems: Dehydration from diarrhea or vomiting can lead to kidney problems.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and discreet way to access weight loss medications. Our EU-licensed doctors provide online consultations to determine the most appropriate treatment plan for your individual needs. We offer:

  • Online Consultations: Skip the waiting room and consult with a doctor from the comfort of your home.
  • Personalized Treatment Plans: Our doctors will review your medical history and lifestyle to create a customized weight loss plan.
  • Prescription Delivery: If appropriate, you'll receive a valid EU prescription in less than 24 hours.
  • Medical Support: Access ongoing support from our medical team through your account dashboard.

Ready to Get Started?

Take the first step towards a healthier you. Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.

hi-doctor.ai Blog

Weight Loss Medication Protocol: Standard Treatment Approaches